Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

Motley Fool

Published

AstraZeneca just released some encouraging data about its weight loss drug candidates.

Full Article